Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

ITI Pharma and Healthcare Fund · Direct ✕Baroda BNP Paribas ESG Best-in-Class Strategy Fund · Direct ✕

Growth of ₹10,000

Basics

ITI Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseITIBaroda BNP
NAV₹20.7004₹10.9097
NAV date20 Nov 202620 Nov 2026
History5.0 years9 months
Expense ratio0.9%1.2%
Stars★★★★★Not rated
Growth Score72.80—

Returns

ITI Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
1 month+11.35%+9.70%
3 months+4.42%+1.66%
6 months+12.33%+6.67%
YTD+21.31%—
1 year+18.01%—
3 years (CAGR)+19.94%—
5 years (CAGR)+15.73%—
10 years (CAGR)——
Since launch+15.56%+8.90%

Risk

ITI Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
Volatility15.9%—
Downside volatility10.1%—
Sharpe0.85—
Sortino1.34—
Calmar1.17—
Return / risk1.25—
Deepest fall−17.69%−10.15%
Days to recover36443
Below its high+0.00%+0.00%

Against benchmark

ITI Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
Alpha−1.30%—
Beta0.98—
R²84.6%—
Up capture94.1%—
Down capture98.8%—
Tracking error6.2%—
Information ratio−0.26—
Treynor0.13—

Consistency

ITI Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
Best 1-year+61.91%—
Middle 1-year+15.57%—
Worst 1-year−9.32%—
1-year periods with a loss21.7%—
Middle 3-year+21.36%—
Positive months72.2%—
Best day+3.48%+2.40%
Worst day−3.28%−1.90%
Worst 5% day−1.48%−1.11%
Positive days56.0%54.3%
NAVs a year247176

SIP of ₹10,000 a month

ITI Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
5-year XIRR——
5-year value——
3-year XIRR+15.60%—
1-year XIRR+27.81%—

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth